Evaluation of limbal conjunctival autograft and low-dose mitomycin C in the treatment of recurrent pterygium
Abstract
BACKGROUND AND OBJECTIVE: To assess the effectiveness of limbal conjunctival autograft and low-dose mitomycin C in the treatment of recurrent pterygium. PATIENTS AND METHODS: Thirty-four eyes with recurrent pterygium underwent surgical excision followed by the intraoperative application of low-dose (0.05%) mitomycin C and the use of limbal conjunctival autograft. All patients were observed for at least 18 months for any complications, including recurrences. RESULTS: Neither recurrences nor serious complications were recorded. Visual acuity improved significantly (P < .05) in eyes with pterygium extending 3 mm or more beyond the limbus. CONCLUSION: Simple excision and low-dose mitomycin C followed by limbal conjunctival autograft is a safe and effective way of treating recurrent pterygium.
Publication Title
Ophthalmic Surgery Lasers and Imaging
Recommended Citation
Nabawi, K., Ghonim, M., & Ali, M. (2003). Evaluation of limbal conjunctival autograft and low-dose mitomycin C in the treatment of recurrent pterygium. Ophthalmic Surgery Lasers and Imaging (3), 193-196. https://doi.org/10.3928/1542-8877-20030501-05
